Vanderbilt Institute for Clinical and Translational Research Archives
How biostatistics saves lives: the Vanderbilt experience
Oct. 17, 2023—Biostatisticians at VUMC have played a pivotal role in the redesign of clinical trials that rigorously and rapidly determine the effectiveness of life-saving treatments for acutely ill patients.
World’s research data administrators descend on Seattle for REDCapCon 2023
Sep. 21, 2023—Institutional research data administrators from around world got their REDCap on at REDCapCon 2023, held Sept. 10-13 in Seattle.
VUMC receives $51 million in NIH grants to improve efficiency of conducting clinical trials across the US
Aug. 9, 2023—Vanderbilt researchers have been awarded two five-year federal grants totaling $51 million to harness new and existing approaches for boosting recruitment and removing roadblocks to the efficiency of conducting clinical trials throughout the country.
Reception honors Gordon Bernard’s decades of service and contributions
Jul. 20, 2023—Gordon Bernard, MD, was honored at a reception on July 19 in recognition of his contributions to Vanderbilt University Medical Center for more than 40 years.
VUMC app used by research participants around the world
May. 24, 2023—MyCap is a secure, customizable mobile computing application (for smartphone or tablet) used to collect data from research participants on a remote basis. At Vanderbilt University Medical Center, where MyCap was created and launched in 2018, some 107 projects have used the app, and by 2021, research participants in 135 countries had installed the free app.
VUMC to coordinate national effort to reduce ARDS, pneumonia, sepsis
May. 4, 2023—Vanderbilt University Medical Center has received a $31.6 million federal grant to lead a national effort to better understand acute respiratory distress syndrome, pneumonia and sepsis.
VUMC-led trial shows two investigational drugs are ineffective for treating severe COVID-19
Apr. 11, 2023—A Vanderbilt-led study evaluating two investigational drugs to treat severe COVID-19 demonstrated that neither drug was effective.
Research Staff Awards honor contributions to discovery
Apr. 6, 2023—by Bill Snyder Laboratory and administrative personnel at Vanderbilt University Medical Center were honored on March 31 for research excellence during the 19th annual Research Staff Awards Ceremony at the Aertson Hotel in Nashville. Presenting the awards were Jennifer Pietenpol, PhD, VUMC Chief Scientific & Strategy Officer, John Kuriyan, PhD, dean of Basic Sciences, Vanderbilt...
VUMC establishes novel Center for Learning Healthcare
Jan. 26, 2023—Vanderbilt University Medical Center has established a first-of-its-kind Center for Learning Healthcare that will bring together clinicians, health system operations leaders and researchers to generate evidence in the course of health care delivery to continuously improve the quality, value and safety of health care offered to patients.
VUMC Announces VICTR Leadership Transition
Dec. 16, 2022—by Bill Snyder Gordon Bernard, MD, a leader in clinical and translational medicine at Vanderbilt University Medical Center for more than 40 years, will step aside from his institutional leadership roles in July 2023 to focus more on his research interests and allow a new generation of leaders to take center stage. Bernard, the Melinda...
Clinical trial at VUMC tests novel treatment for asthma
Nov. 10, 2022—VUMC has begun enrolling patients with asthma in a clinical trial of a novel treatment: a medication approved to treat diabetes and obesity.
Conference highlights REDCap’s global reach
Sep. 29, 2022—REDCap administrators from around the world recently attended the 14th edition of REDCapCon in Boston, hosted this year by Harvard Catalyst, Harvard University’s center for clinical and translational science.
